Your browser doesn't support javascript.
loading
A 2.5-Year Weight Management Program Using Noom Health: Protocol for a Randomized Controlled Trial.
Sysko, Robyn; Bibeau, Jessica; Boyar, Allison; Costello, Kayla; Michaelides, Andreas; Mitchell, Ellen Siobhan; Susanin, Annabel; Hildebrandt, Tom.
Afiliação
  • Sysko R; Eating and Weight Disorders Program, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Bibeau J; Eating and Weight Disorders Program, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Boyar A; Eating and Weight Disorders Program, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Costello K; Eating and Weight Disorders Program, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Michaelides A; Noom Inc, New York, NY, United States.
  • Mitchell ES; Noom Inc, New York, NY, United States.
  • Susanin A; Eating and Weight Disorders Program, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
  • Hildebrandt T; Eating and Weight Disorders Program, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
JMIR Res Protoc ; 11(8): e37541, 2022 Aug 12.
Article em En | MEDLINE | ID: mdl-35969439
ABSTRACT

BACKGROUND:

Overweight and obesity are serious public health concerns. As the prevalence of excess weight among individuals continues to increase, there is a parallel need for inexpensive, highly accessible, and evidence-based weight loss programs.

OBJECTIVE:

This weight loss trial will aim to examine the efficacy of the Noom weight loss program in comparison to a digital control after a 6-month intervention phase and a 24-month maintenance phase, with assessments continuing for 2 years beyond the intervention (to 30 months-after the baseline). The secondary outcomes include quality of life, psychosocial functioning, sleep quality, physical activity, diet, and health status. This trial will also examine the severity of obesity-related functional impairment, weight loss history, and demographic moderators, along with adherence and self-efficacy as mediators of the outcome.

METHODS:

A total of 600 participants were randomized in a parallel-group, controlled trial to either Noom Healthy Weight Program (intervention) or Noom Healthy Weight Control (control) for a 6-month intervention. Both intervention and control groups include diet and exercise recommendations, educational content, daily logging capabilities, and daily weigh-in entries. The Noom Healthy Weight Program also includes a coach support for weight loss. Remote follow-up assessments of eating, physical activity, psychosocial factors, app use data, and weight will be conducted at 1, 4, 6, 12, 18, 24, and 30 months after baseline. Weight is measured at each follow-up point during a Zoom call using the participants' scales.

RESULTS:

Enrollment began in March 2021 and the 6-month intervention phase ended in March 2022. Data collection for the final assessment will be completed in March 2024.

CONCLUSIONS:

This study tests commercially available digital lifestyle interventions for individuals with overweight and obesity seeking weight loss support. Data obtained from the study will evaluate whether the Noom Healthy Weight Control Program can help individuals overcome weight loss, achieve long-term maintenance, adhere to lifestyle changes, and feature use barriers that are present in other traditional weight loss treatments. TRIAL REGISTRATION ClinicalTrials.gov NCT04797169; https//clinicaltrials.gov/ct2/show/NCT04797169. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID) DERR1-10.2196/37541.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: JMIR Res Protoc Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: JMIR Res Protoc Ano de publicação: 2022 Tipo de documento: Article